Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
10,829.3588.0
Stock Analysis, IPO, Mutual Funds, Bonds & More

Dr Reddys launches anti-phlegm OTC drug in US market

OTC Guaifenesin and Pseudoephedrine HCl is used to help loosen phlegm (mucus) and thin bronchial secretions.

PTI|
Jul 09, 2019, 03.04 PM IST
0Comments
BCCL
medicine_bccl
The Mucinex D brand and store brands had combined US sales of approximately $71 million MAT for the most recent 12 months.
Hyderabad: Dr Reddys Laboratories Ltd Tuesday announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex D extended release tablets in two strengths.

The OTC Guaifenesin and Pseudoephedrine HCl is used to help loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus, a press release from the company said.

"We are excited to bring first to the market the store-brand equivalent of Mucinex D maximum strength extended release tablets. The launch illustrates our continued commitment to the OTC business and our growing portfolio in the cough, cold and allergy category," Milan Kalawadia, senior vice-president and head of US (OTC and specialty Rx divisions), Dr Reddys, said in the release.

The Mucinex D brand and store brands had combined US sales of approximately USD 71 million MAT (moving annual turnover) for the most recent 12 months ending May 2019, the release said quoting market reports, the release said.

The OTC product is available as Guaifenesin 600 mg and and Pseudoephedrine HCl 60 mg and Guaifenesin 1200 mg and Pseudoephedrine HCl 120 mg strengths, it said.
0Comments

Also Read

Dr Reddy's launches Roche's Avastin biosimilar in India

Dr Reddy’s Labs down after USFDA observations

Dr Reddy's launches generic oral anti-epileptic drug in US

70 products in pipeline,Dr Reddy's bullish on China

Buy Dr. Reddy's Laboratories, target Rs 2780: Kunal Bothra

Comments
Add Your Comments
Commenting feature is disabled in your country/region.
Download The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service